1 – 34 of 34
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
(
- Contribution to journal › Article
-
Mark
Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair
2023) In Clinical cancer research : an official journal of the American Association for Cancer Research 29(22). p.4644-4659(
- Contribution to journal › Article
- 2022
-
Mark
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
(
- Contribution to journal › Scientific review
-
Mark
Latest developments in metal complexes as anticancer agents
(
- Contribution to journal › Scientific review
-
Mark
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
(
- Contribution to journal › Article
- 2021
-
Mark
In vitro nephrotoxicity studies of established and experimental platinum-based compounds
(
- Contribution to journal › Article
- 2020
-
Mark
Cryogels with high cisplatin adsorption capacity : Towards removal of cytotoxic drugs from wastewater
(
- Contribution to journal › Article
- 2019
-
Mark
A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin
(
- Contribution to journal › Article
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
(
- Contribution to journal › Article
- 2018
-
Mark
Tumor Regression and Cure Depends on Sustained Th1 Responses
(
- Contribution to journal › Article
- 2015
-
Mark
Integrin β1, osmosensing, and chemoresistance in mouse ehrlich carcinoma cells
(
- Contribution to journal › Article
- 2014
-
Mark
Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
(
- Contribution to journal › Article
- 2013
-
Mark
Combined chemotherapy and immunotherapy against experimental malignant brain tumors
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Comparison of Cis- and Oxaliplatin-induced Destabilization of 15-mer DNA- and RNA Duplexes by Binding to Centrally Located GG- and GNG Sequences
(
- Contribution to journal › Article
-
Mark
Nucleic Acids as Drug Targets - Influence of Platinum Complexes on Duplex Stability and Binding Kinetics
2013)(
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Increased toxicity of a trinuclear Pt-compound in a human squamous carcinoma cell line by polyamine depletion
(
- Contribution to journal › Article
- 2011
-
Mark
Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: Satellite-A phase II study from the Swedish Lung Cancer Study Group
(
- Contribution to journal › Article
-
Mark
Nucleic Acids as Drugs and Drug Targets With Focus on Anticancer Active Platinum Complexes and Small Interfering RNAs
2011)(
- Thesis › Doctoral thesis (compilation)
-
Mark
MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells
(
- Contribution to journal › Article
- 2010
-
Mark
Synthesis and DNA Interaction of Platinum Complex/Peptide Chimera as Potential Drug Candidates
(
- Contribution to journal › Article
- 2008
-
Mark
Cisplatin and siRNA interference with structure and function of Wnt-5a mRNA: design and in vitro evaluation of targeting AU-rich elements in the 3' UTR.
(
- Contribution to journal › Article
-
Mark
PREDICTIVE AND PROGNOSTIC MARKERS IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Role of homologous recombination in trabectedin-induced DNA damage
(
- Contribution to journal › Article
-
Mark
Cationic Interactions with Nucleic Acids With Focus on Anticancer Active Platinum(II) Complexes
2008)(
- Thesis › Doctoral thesis (compilation)
- 2007
-
Mark
Influence of cisplatin on RNA structure in solution Escherichia coli tRNA(Ala) and human Wnt-5a 3' UTR model system studies
2007)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Nucleic Acids as Drug Targets -Interactions of Platinum Complexes, Polyamines, and siRNA with DNA and RNA Models
2007)(
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
Synthesis and structural characterisation of novel platinum-based drug candidates with extended functionality by incorporation of bis(diphenylphosphino)ferrocene units as metal chelators
(
- Contribution to journal › Article
- 2001
-
Mark
Antitumor effect of radioactive cisplatin (191Pt) on nude mice
(
- Contribution to journal › Article
-
Mark
Reactions of Model and Anticancer Active Platinum(IV/II) Complexes - A Kinetic and Mechanistic Study
2001)(
- Thesis › Doctoral thesis (compilation)
- 2000
-
Mark
Studies of radioactive cisplatin (191Pt) for tumour imaging and therapy
2000)(
- Thesis › Doctoral thesis (compilation)
- 1999
-
Mark
Cisplatin at clinically relevant concentrations enhances interleukin-2 synthesis by human primary blood lymphocytes
(
- Contribution to journal › Article
- 1998
-
Mark
Transition Metal Complexes and Precursors. 23. Facile Synthesis of Isomerically Pure cis-Dichlorodiammineplatinum(II), CISPLATIN
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 1996
-
Mark
Pharmacokinetic and pharmacodynamic studies on cisplatin in mice and men
1996)(
- Thesis › Doctoral thesis (compilation)
- 1991
-
Mark
Guanine-O6 Methylation Reduces the Reactivity of D(GpG) towards Platinum Complexes
(
- Contribution to journal › Article